PH10416A - Substituted cyclopentane derivatives - Google Patents

Substituted cyclopentane derivatives

Info

Publication number
PH10416A
PH10416A PH15889A PH15889A PH10416A PH 10416 A PH10416 A PH 10416A PH 15889 A PH15889 A PH 15889A PH 15889 A PH15889 A PH 15889A PH 10416 A PH10416 A PH 10416A
Authority
PH
Philippines
Prior art keywords
substituted cyclopentane
cyclopentane derivatives
derivatives
substituted
cyclopentane
Prior art date
Application number
PH15889A
Inventor
H Hess
T Schaaf
L Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH10416A publication Critical patent/PH10416A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH15889A 1971-09-01 1974-06-03 Substituted cyclopentane derivatives PH10416A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01

Publications (1)

Publication Number Publication Date
PH10416A true PH10416A (en) 1977-03-16

Family

ID=22647201

Family Applications (3)

Application Number Title Priority Date Filing Date
PH13850A PH10023A (en) 1971-09-01 1972-08-29 Tetrazoyl derivatives of naturally occurring prostagladines
PH15888A PH10443A (en) 1971-09-01 1974-06-03 Cyclopentanelactones and hemiacetals
PH15889A PH10416A (en) 1971-09-01 1974-06-03 Substituted cyclopentane derivatives

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PH13850A PH10023A (en) 1971-09-01 1972-08-29 Tetrazoyl derivatives of naturally occurring prostagladines
PH15888A PH10443A (en) 1971-09-01 1974-06-03 Cyclopentanelactones and hemiacetals

Country Status (12)

Country Link
JP (1) JPS5724348B2 (en)
AR (4) AR197304A1 (en)
AT (3) ATA51974A (en)
CA (1) CA978939A (en)
DK (1) DK144730C (en)
ES (3) ES406250A1 (en)
FI (1) FI55497C (en)
FR (3) FR2283136A1 (en)
IL (3) IL48544A (en)
PH (3) PH10023A (en)
SE (4) SE409032B (en)
ZA (1) ZA725827B (en)

Also Published As

Publication number Publication date
FI55497B (en) 1979-04-30
AT335079B (en) 1977-02-25
AR199574A1 (en) 1974-09-13
FR2283147B1 (en) 1978-05-12
ATA743472A (en) 1976-06-15
ES417557A1 (en) 1976-06-16
CA978939A (en) 1975-12-02
SE7606691L (en) 1976-06-11
ZA725827B (en) 1973-06-27
JPS4834165A (en) 1973-05-16
AT327219B (en) 1976-01-26
ES417558A1 (en) 1976-06-16
ES406250A1 (en) 1976-06-01
SE424185B (en) 1982-07-05
AR197304A1 (en) 1974-03-29
FI55497C (en) 1979-08-10
AR199573A1 (en) 1974-09-13
AR199784A1 (en) 1974-09-30
SE421526B (en) 1982-01-04
SE7606689L (en) 1976-06-11
IL40183A (en) 1977-06-30
IL48544A (en) 1977-06-30
SE7606690L (en) 1976-06-11
ATA51974A (en) 1975-04-15
PH10023A (en) 1976-07-13
FR2283134A1 (en) 1976-03-26
FR2283134B1 (en) 1978-05-12
PH10443A (en) 1977-03-25
FR2283136B1 (en) 1978-05-12
FR2283147A1 (en) 1976-03-26
IL40183A0 (en) 1972-10-29
FR2283136A1 (en) 1976-03-26
SE409032B (en) 1979-07-23
SE421525B (en) 1982-01-04
JPS5724348B2 (en) 1982-05-24
IL48544A0 (en) 1976-01-30
DK144730C (en) 1982-10-18
DK144730B (en) 1982-05-24

Similar Documents

Publication Publication Date Title
IL38605A0 (en) P-methane-carboxamide derivatives
IE36079L (en) Benzazine derivatives
MY7900027A (en) 3-substituted-morphinan derivatives
HK50176A (en) Cyclopentane derivatives
HK22577A (en) Oxidiazolone derivatives
ZA728312B (en) Isiondoline derivatives
ZA722873B (en) Cyclopentane derivatives
ZA724723B (en) 2-nitro-5-imidazolaldehyde derivatives
IL38936A0 (en) Lumilysergol derivatives
ZA72165B (en) Substituted m-trifluormethylphenylurea derivatives
ZA724234B (en) Cyclopentane derivatives
CY908A (en) Triazolyl-ethenyl-phenylene derivatives
GB1408201A (en) Adenosine-5-carboxylate derivatives
GB1402325A (en) Dibenzoxirenoazepine derivatives
IE37196L (en) Diphenylpyrazolium derivatives
ZA72713B (en) Cyclopentane derivatives
ZA721356B (en) Benzodiazane derivatives
IL39834A (en) Beta-phenyl-beta-fluoroethane derivatives
MY7900211A (en) 2-aminomethylphenol derivatives
GB1401806A (en) Methylene-dioxyquinazoline derivatives
PH10416A (en) Substituted cyclopentane derivatives
IE37025L (en) Cyclopentane derivatives.
ZA724013B (en) Cyclopentane derivatives
ZA724372B (en) Cyclopentane derivatives
PH10343A (en) Dihydro-2-aminoisoquinolinone derivatives